| Trial ID: | L1178 |
| Source ID: | NCT01066351
|
| Associated Drug: |
Beta Erythropoietin
|
| Title: |
Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Acute Renal Failure
|
| Interventions: |
DRUG: beta erythropoietin|DRUG: placebo
|
| Outcome Measures: |
Primary: The primary end-point of this study is the development of AKI in placebo group compared with EPO group., 1.5 year | Secondary: The secondary end-point of this study is compare urine NGAL level in AKI patients between both groups, 1.5 year
|
| Sponsor/Collaborators: |
Sponsor: Thammasat University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
200
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2010-01
|
| Completion Date: |
2011-06
|
| Results First Posted: |
|
| Last Update Posted: |
2010-02-10
|
| Locations: |
Adis Tasanarong, Khlong Luang, Pathumtani, 12121, Thailand
|
| URL: |
https://clinicaltrials.gov/show/NCT01066351
|
